Lopinavir-ritonavir
Boosted protease inhibitor for HIV, mostly used as a second-line option.
- Starts working
- Weeks
- Half-life
- 5–6 hours
- In use since
- —
- Pregnancy
- Generally considered safe
Overview
Lopinavir is boosted with a low dose of ritonavir to reach effective levels. It is widely used in second-line regimens, children and pregnancy, but causes diarrhoea and lipid increases.
Conditions it's used for
How it works
Stops HIV from maturing into infectious viruses.
Lopinavir-ritonavir belongs to the Viral protease inhibitors. How Viral protease inhibitors work: block the viral 'scissors' enzyme, so the long protein chain the virus makes cannot be cut into working pieces.
Uses
- HIV infection (with other drugs)
Available as: tablet, oral solution.
Typical dose
- Adults
- 400/100 mg twice a day, or 800/200 mg once a day in some patients.
- Children
- Weight-based dosing.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Diarrhoea
- Nausea
- Raised cholesterol and triglycerides
- Tiredness
Serious — get medical help
Uncommon, but need prompt attention
- Pancreatitis
- Liver injury
- QT and PR prolongation
- Insulin resistance
Warnings
- Interacts with many medicines
- Lipid and glucose monitoring
Who should avoid it
- Taking simvastatin, lovastatin, rifampicin, St John's wort
- Severe liver disease
Interactions
- Simvastatin, lovastatin — contraindicated
- Rivaroxaban, apixaban — raised levels
- Hormonal contraceptives — less reliable
- Rifampicin — large drop in levels
- Sildenafil, tadalafil — raised levels
- Many other medicines
Other medicines in the atlas that need care with Lopinavir-ritonavir, grouped by the reason:
Dangerous rise in drug levelsMajorWith Ciclosporin, Colchicine, Fentanyl, Midazolam, Simvastatin and 3 more
A strong CYP3A4 inhibitor blocks breakdown of a drug where higher levels are hazardous (e.g. simvastatin — muscle breakdown; colchicine — fatal toxicity; tacrolimus — kidney damage; fentanyl or midazolam — breathing suppression).
What's usually done: Usually contraindicated or needs a planned pause or major dose change. Always check with a pharmacist.
More anticoagulant effectMajorWith Apixaban, Dabigatran, Edoxaban, Rivaroxaban
Combined P-glycoprotein and strong CYP3A4 inhibition can raise apixaban or rivaroxaban exposure and increase bleeding.
What's usually done: Follow the apixaban or rivaroxaban label: avoid or reduce the DOAC dose as directed with strong dual inhibitors.
Colchicine toxicityMajorWith Colchicine
Transporter inhibition can raise colchicine exposure; toxicity may cause severe diarrhoea, muscle injury, bone-marrow suppression or organ failure.
What's usually done: Avoid many combinations, especially with kidney or liver disease. Use a lower dose only under specialist advice.
Digoxin toxicityMajorWith Digoxin
P-glycoprotein inhibition can raise digoxin levels, increasing the risk of nausea, visual changes, confusion and dangerous heart rhythms.
What's usually done: Check the digoxin level and kidney function; a dose reduction may be needed.
Raised drug levelsModerateWith Abiraterone, Alfuzosin, Alprazolam, Amlodipine, Apremilast and 55 more
Blocking CYP3A4 increases levels of this medicine, so side effects become more likely.
What's usually done: A dose reduction, alternative or extra monitoring may be needed.
Higher rhythm riskModerateWith Amiodarone, Amisulpride, Amitriptyline, Artemether–lumefantrine, Azithromycin and 38 more
Some CYP3A4 inhibitors raise concentrations of QT-prolonging medicines, adding to the risk of torsades and fainting.
What's usually done: Avoid high-risk combinations where possible; review the specific medicine and consider ECG monitoring.
Low blood sugarModerateWith Glibenclamide, Gliclazide, Glimepiride, Glipizide
Some CYP3A4 inhibitors increase exposure to sulfonylureas, making hypoglycaemia more likely.
What's usually done: Check glucose more often and review the diabetes dose when the inhibitor starts or stops.
INR may riseModerateWith Warfarin
Some CYP3A4 inhibitors can slow warfarin metabolism and increase anticoagulant effect.
What's usually done: Check INR soon after starting or stopping the inhibitor and adjust warfarin only through the anticoagulation service.
Using it safely
- Alcohol
- Best to limit. Alcohol increases pancreatitis and liver risk.
- Food and drink
- Tablets with or without food; solution with food.
- If you miss a dose
- Take when remembered; skip if near the next dose.
- Stopping it
- Do not stop without advice.
- Driving
- Dizziness and tiredness possible.
- Tests and checks
- Viral load; Lipids; Glucose; Liver tests; ECG if risk factors
- If too much is taken
- Rhythm changes and pancreatitis. Seek help.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Generally considered safe
Widely used in pregnancy within HIV regimens.
Breastfeeding
Usually avoided
Not recommended where safe formula is available.
Special groups
- Liver disease
- Use caution in liver disease.
- Older adults
- Check lipid and glucose changes.
Brand names
- United States
- Kaletra
- United Kingdom
- Kaletra
- India
- Lopimune, Lopinavir-ritonavir (generic)
- Australia
- Kaletra
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Lopinavir-ritonavir?
Yes — Lopinavir-ritonavir is prescription-only in most countries.
Can I take Lopinavir-ritonavir during pregnancy?
Generally considered safe. Widely used in pregnancy within HIV regimens. Always check with a doctor or midwife.
How quickly does Lopinavir-ritonavir work?
Weeks.
Related medicines
Dolutegravir
Core of the WHO-preferred HIV treatment.
RxWHOIntegrase inhibitorsTenofovir disoproxil
Backbone drug for HIV treatment, PrEP and hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsLamivudine
Backbone antiretroviral also active against hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsEfavirenz
NNRTI used in first-line HIV regimens, with vivid dreams as a common side effect.
RxWHONon-nucleoside reverse transcriptase inhibitorsDarunavir
Potent boosted protease inhibitor for HIV with resistance.
RxViral protease inhibitorsNirmatrelvir–ritonavir
COVID-19 antiviral pills for people at high risk.
RxViral protease inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — J05AR10
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.